Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial

収録刊行物

被引用文献 (8)*注記

もっと見る

問題の指摘

ページトップへ